Minor, PD. The molecular biology of polio vaccines. Journal of General Virology
1992; 73: 3065–3077.
Fine, PEM, Carneiro, IAM. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. American Journal of Epidemiology
1999; 150: 1001–1021.
Martin, J. Vaccine-derived poliovirus from long term excretors and the endgame of polio eradication. Biologicals
2006; 34: 117–122.
Abraham, R, et al.
Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. Journal of Infectious Diseases
1993; 168: 1105–1109.
Minor, P. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine
2009; 27: 2649–2652.
Platt, LR, Estívariz, CF, Sutter, RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. Journal of Infectious Diseases
2014; 210 (Suppl. 1): S380–389.
Korotkova, EA, et al.
A cluster of paralytic poliomyelitis cases due to transmission of slightly diverged Sabin-2 vaccine virus. Journal of Virology
2016; 90: 5978–5988.
Wassilak, S, et al.
Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population. Journal of Infectious Diseases
2011; 203: 898–909.
CDC. Update on vaccine-derived polioviruses worldwide, January 2008–June 2009. Morbidity and Mortality Weekly Report
2009; 58: 1002–1006.
Liu, H-M, et al.
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. Journal of Virology
2003; 77: 10994–11005.
Combelas, N, et al.
Recombination between poliovirus and coxsackie a viruses of species C: a model of viral genetic plasticity and emergence. Viruses
2011; 3: 1460–1484.
Burns, CC, et al.
Vaccine-derived polioviruses. Journal of Infectious Diseases
2014; 210 (Suppl. 1): S283–S293.
CDC. Public Health Dispatch: Update: outbreak of poliomyelitis – Dominican Republic and Haiti, 2000–2001. Morbidity and Mortality Weekly Report
2001; 50: 855–856.
Wringe, A, et al.
Estimating the extent of vaccine-derived poliovirus infection. PLoS ONE
2008; 3: e3433.
Yang, CF, et al.
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. Journal of Virology
2003; 77: 8366–8377.
Morales, M, Tangermann, RH, Wassilak, SG. Progress toward polio eradication – worldwide, 2015–2016. Morbidity and Mortality Weekly Report
2016; 65: 470–473.
Yates, MV, Gerba, CP, Kelley, LM. Virus persistence in groundwater. Applied and Environmental Microbiology
1985; 49: 778–781.
Yorke, JA, et al.
Seasonality and the requirements for perpetuation and eradication of viruses in populations. American Journal of Epidemiology
1979; 109: 103–23.
Duintjer Tebbens, RJ, Thompson, KM. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. Journal of Infectious Diseases
2014; 210 (Suppl. 1): S485–S497.
Anis, E, et al.
Insidious reintroduction of wild poliovirus into Israel, 2013. Eurosurveillance
2013; 18: pii = 20586.
Kaliner, E, et al.
The Israeli public health response to wild poliovirus importation. Lancet Infectious Diseases
2015; 15: 1236–1242.
Asturias, EJ, et al.
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial. Lancet
2016; 388: 158–169.
Al-Hello, H, et al.
Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia. Journal of Virology
2013; 87: 13076–13080.
Roivainen, M, et al.
Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Eurosurveillance
2010; 15: pii = 19566.
Conyn-van Spaendonck, MA, et al.
Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992–1993. American Journal of Epidemiology
1996; 143: 929–935.
Eichner, M, Dietz, K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?
American Journal of Epidemiology
1996; 143: 816–822.
Shaghaghi, M, et al.
Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995–2014. Emerging Infectious Diseases
2016; 22: 1712–1719.
Duizer, E, et al.
Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014. Eurosurveillance
2016; 21: pii = 30169.
Duintjer Tebbens, RJ, Hampton, LM, Thompson, KM. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use. BMC Infectious Diseases
2016; 16: 237.